A Study of Two Versions of the Uresta Pessary Handle for Women With Stress Urinary Incontinence
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Resilia Inc.
- Study ID
- NCT07706491
- Status
- Completed
Conditions
- Stress Urinary Incontinence (SUI)
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- pessary handle — DEVICEthe participants will use two pessary handle designs as well as an optional pessary puller string and complete questionnaires to rate their experience
Study Details
The goal of this clinical trial is to learn if a new handle design for the uresta pessary works better than the current handle design for women when they are using the pessary. The main questions it aims to answer are: Is the new pessary equally effective for users. Do pessary users find the new handle design is more or less helpful for insertion and removal of the pessary Is the optional removal string, provided with the new handle, helpful in pessary handling. The participants will use both the original and the new uresta pessary handle designs and complete a questionnaire to rate both handles. The score for the two questionnaires will be compared to determine which handle is best.
Key Dates
- First listed
- Jul 15, 2026
- Start date
- Apr 20, 2026
- Status verified
- Jul 2026
- Primary completion
- Jun 18, 2026
- Completion
- Jun 18, 2026
Study Design
- Enrollment
- 113 participants (actual)
- Allocation
- NA
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Other: pessary handle comparison armsingle arm, sequential use of two pessary handle designs
Primary Outcome Measure
questionnaire [ Time Frame: From enrolment to completion at 4 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stirling IRB | Atlanta | Georgia | 30339 | - |
Find similar trials in Atlanta, GA
Related Studies
- A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)Recruiting · UroMems SAS · Los Angeles, California
- Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive SurgeryPHASE4 · Not Yet Recruiting · University of California, Los Angeles · Los Angeles, California